DG Comp and Canada clear pharmaceutical merger
Tuesday, 10 August 2010
Faaez Samadi
The European Commission and Canada’s Competition Bureau yesterday both approved the acquisition of pharmaceutical company Alcon by rival Novartis, subject to divestitures.
PREMIUM Subscription required to view this article
This content can only be accessed by PREMIUM GCR subscribers.
A premium subscription includes 10 issues of the journal, 2 signature surveys - The GCR100 and Rating Enforcement, 10 GCR special reports and full access to current and archived print & online content.
If you are a GCR subscriber, please login to access this content:
Comments
You must Subscribe or Log In to make comments.
Comment Terms & Conditions
Back to top